Search

Store Search

Oncology

Product availability
in stock
SKU
0050
Active substance
Krizotinib, 250 mg
Diagnosis
Oncology
The country
Bangladesh
Manufacturer
Beacon Pharmaceuticals
Product availability
in stock
SKU
0051
Active substance
Abiraterone, 250 mg
Diagnosis
Oncology
The country
India
Manufacturer
Cipla Ltd
Product availability
in stock
SKU
0052
Active substance
Osimertinib, 80 mg
Diagnosis
Oncology
The country
Bangladesh
Manufacturer
Beacon Pharmaceuticals
Product availability
in stock
SKU
0054
Active substance
Lenvatinib, 4 mg
Diagnosis
Oncology
The country
Canada
Manufacturer
Eisai
Product availability
in stock
SKU
0055
Active substance
Vemurafenib, 240 mg
Diagnosis
Oncology
The country
India
Product availability
in stock
SKU
0057
Active substance
Pazopanib, 400 mg
Diagnosis
Oncology
The country
Great Britain
Manufacturer
GlaxoSmithKline
Product availability
in stock
SKU
0058
Active substance
Abiraterone, 250 mg
Diagnosis
Oncology
The country
India
Manufacturer
Glenmark Pharmaceuticals Limited
Product availability
in stock
SKU
0059
Active substance
Lenalidomide, 25 mg
Diagnosis
Oncology
The country
India
Manufacturer
Natco Pharma Ltd
Product availability
in stock
SKU
0060
Active substance
Lenalidomide, 15 mg
Diagnosis
Oncology
The country
India
Manufacturer
Natco Pharma Ltd

TREATMENT OF HEPATITIS AND ONCOLOGY

Certificates

All drugs are certified.

License for the sale of medicines No. 23456789 dated 20.11.2013

WHO GMP Certified Company

© 2020-2022 The site is for informational purposes ONLY and does not trade via the Internet.